With the addition of Dr. Caitilin Hamill, Medpace strengthens its ability to provide Sponsors guidance and support in all stages of their product development programs, especially in some of the industry’s most complex scientific areas.
Read More
“This partnership strengthens our global Regulatory Affairs offering and allows us to expand our strategic capabilities to support our Sponsors’ programs.” – Jon Isaacsohn, MD, FACC, Executive Vice President at Medpace.
Read More
Author: Wanda Dobrzanski M.D, Head of Clinical Operations Latin America, Medpace
On April 26th, The Ministry of Health in Argentina (ANMAT) issued a new regulation that significantly reduces the timelines for the approval of clinical trials. In this post, I discuss the key changes and the advantages this offers Sponsors who are looking to conduct clinical trials in Latin America.
Read More